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1. Introduction 
Protein A is a cell-wall constituent from Staphylo- 
coccus UUI~W [ 1,2] with the ability to react with non- 
immune immunoglobulins from several mammalia 
[3,4]. The active binding site for protein A is situated 
in the Fc-region of human IgCl, IgG2 and IgG4 [ 561. 
As a consequence of the reaction, the complement 
system, for instance, is activated, as well as certain 
immunological reactions are initiated in vivo [7-91. 
Tyrosine-modifying reagents inhibit the reactivity 
of protein A, as shown by nitration, acetylation and 
iodination [lo- 121. The circular dichroism (CD) spec- 
trum of protein A is very characteristic with strong, 
well separated bands at 261 and 268 nm originating 
from the phenylalanine residues [ 131. The condi- 
tions to detect changes of the intrinsic Cotton effects 
resulting from the protein A-IgG interaction can 
therefore be considered as relatively good, especially 
as an isolated Fc-fragment can be used instead of 
the complete y-globulin. Thereby, the ellipticity back- 
ground from the non-reacting Fab-fragments can be 
avoided, which means that any specific conformational 
changes can be detected more easily. The present 
paper describes the CDchanges seen, when protein 
A interacts with the Fc-fragment of a human myeloma 
protein. 
2. Materials and methods 
Protein A was obtained after lysostaphin digestion 
of the bacteria S. aureus, strain Cowan 1, as described 
earlier [10,14]. 
North-Holland Publishing Company - Amsterdam 
A myeloma IgG (GN) was kindly provided by 
Professor J. Sjoquist, Uppsala. It was digested with 
papain according to Porter [ 151 and the monomer of 
the Fc-fragment isolated by chromatography on DEAE- 
Sephadex A-50 and gelfiltration on Sephadex. 
CD measurements were performed on an automatic 
spectropolarimeter, JASCO J-20, Japan Spectroscopic 
Co., Tokyo, in a thermostated cellholder at 25’C. The 
proteins were solved in 0.1 M KC1 at pH 7.3-7.4. The 
concentration was checked in a recording double- 
beam spectrophotometer, Cary 15, after filtration. The 
scanning was started at least 20 min after protein A 
and the Fc-fragment were mixed. The ellipticity is 
expressed as molar ellipticity, 8, degrees X cm2 X 
dmol-’ for the separate protein samples, with the 
mol. wt 42 000 and 55 000 of protein A and the Fc- 
fragment, respectively. For the mixtures, the ellipticity, 
13 or A0 is expressed in degrees and the concentrations 
of the components given as mg per ml. 
3. Results 
Fig. 1 shows the CD spectra of the protein A and 
the Fc-fragment preparations used in the present 
studies. The spectrum of protein A corresponds 
closely to those earlier published [l l-131, and that 
of the Fc-fragment has the same general characteristics 
as the CDspectrum of Fc, shown by Ghose [ 161. 
Protein A and the Fc-fragment of the myeloma IgG 
GN form soluble complexes. Fig.2 shows the spectrum 
of a mixture of the Fc-fragment and protein A in a 
molar ratio of 1:2.45 (or 0.408: l), which means that 
protein A is added in a concentration far over the 
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Fig.1. Circular dichroism spectra of protein A (o-o-o) and 
the Fc-fragment of a myeloma IgG (GN) (a-e-0) at pH 7.3 
and 25°C in 0.1 M KCl. The vertical bars show the noise level. 
equivalent amount. The spectrum is compared with 
the theoretical spectrum obtained by a summation of 
the ellipticities from each of the separate components. 
As is evident from the figure, there are significant 
differences between the two spectra. The most striking 
effect is the partial loss of the characteristic negative 
peaks at 268 and 261 nm, which will be shown 
clearly also in the difference spectra (fig.3). Below 
about 292 nm, the whole spectrum has been less 
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Fig.2. Circular dichroism spectra of a mixture of protein A 
(1.28 mg/ml) and Fc-fragment (0.66 mg/ml) at pH 7.3 and 
25°C in 0.1 M KC1 (o-o-o) compared with a calculated 
spectrum constructed from the ellipticity of the respective 
components (o-o-o). The cell pathlength was 20 mm. The 
vertical bars show the noise level. 
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Fig.3. Difference circular dichroism spectra of protein A-Fc 
complexes at pH 7.3 and 25°C in 0.1 M KCI. The concentra- 
tion of EC-fragment is 0.657 mg/ml and that of protein 
A 0.19 mg/ml (o-o-o), 0.35 mg/ml (o-*-e) and 0.56 
mg/ml (+-+-+). The spectra shown are obtained by 
subtracting the sum of the ellipticity contribution of the 
different components from the experimental spectra obtained 
of the mixtures. The cell pathlength was 20 mm. 
negative. The relative decrease is about 40% at 289 
nm and almost 20% at 264 nm. The same qualitative 
changes have been seen with two different combina- 
tions of different Fc- and protein A-preparations. 
Addition of increasing amounts of protein A to the 
Fc-fragment will gradually change the CD spectrum. 
In fig.3, the difference spectra have been calculated 
as the difference between the experimental CD spectra 
and the theoretical ones for different mixtures of the 
Fc-fragment and protein A. In these experiments, the 
concentration of the Fc-fragment was kept constant 
(0.66 mg/ml), while that of protein A was increased 
from 0.19 to 0.56 mglml. The molar ratio between 
Fc-fragment and protein A thus changes from 
1:0.395 to 1:0.709 to l:l.ll (or 2.53:1, 1.41:1 and 
0.90: 1, respectively) in the mixtures. The spectra will 
show the changes of the intrinsic Cotton effects 
resulted from the conformational changes brought 
about during the complex formation. In the wave- 
length region under study the ellipticity is given by 
the aromatic amino-acid side-chains (from phenylalan- 
ine, tyrosine and tryptophan), as well as by disulfide 
bonds. 
The noise level of the primary spectra was low as 
shown in figs. 1 and 2, and the difference spectra 
shown in fig.3 can thus be considered to be significant. 
They show that the conformation of the proteins is 
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considerably affected by the complex formation. The 
spectra show maxima at 262-263, 268, 275,280, 289 
nm and possibly a negative one at 305 nm. This means 
that all the aromatic amino acids are involved in the 
conformational changes. Several studies with model 
compounds or proteins have detected separated transi- 
tions of these amino acids in this region. The two lower 
peaks (262-263 and 268 nm) most probably originate 
from phenyl-alanine residues [ 13,17,18] and tyrosine 
residues show several transitions from 273 nm up to 
288.5 nm [19,20]. Finally, tryptophan also will show 
several transitions between 288-305 nm [21]. 
4. Discussion 
When protein A is added to IgG-Fc at pH 7.3 the 
CD spectra show significant deviations from the 
theoretical ones in all the wavelength region studied 
(250-306 nm). The deviations are easily detected and 
are expressed as a decreased negative ellipticity 
amounting to almost 20% at 264 nm and about 40% 
at 289 nm. Moreover, both phenylalanine, tyrosine 
and tryptophan residues seem to be involved as judged 
by the composition of the difference spectra (flg.3). 
AI1 the results, considering the magnitude of the 
changes and the amino acids involved, indicate that 
the interaction is accompanied by extensive conforma- 
tional changes. 
The protein A-IgG(GN)-Fc complex does not 
form precipitates (and nor does the complex with 
complete IgG (GN)), but precipitation studies with 
non-immune, normal IgG showed that the molar ratio 
of IgG to protein A was 2.1: 1 in the equivalence zone 
[ 141. This means that almost all IgG molecules are 
engaged in the reaction already at the lowest protein 
A concentration used at a molar ratio of 2.53: 1 (or 
1:0.395) of Fc to protein A (fig.3). With increasing 
concentrations of protein A, the CD spectra at 285- 
306 were not further changed. Thus, most probably 
this part of the spectrum illustrates the events taking 
place at Fc-excess. The wavelength localization of this 
spectral change indicates that tryptophan residues are 
involved. As protein A does not contain tryptophan, 
the spectral change detected has arisen from changes 
in the primary active binding site of the Fc-fragment 
or from parts of the Fc-fragment, the conformation 
of which is influenced by the binding site. As changes 
of the ellipticity are detected also in the rest of the 
wavelength region, tyrosines and phenylalanines 
should be involved, too. 
When the concentration of protein A is increased 
over the equivalence concentration, the ellipticity 
deviation successively increases from the theoretical 
ellipticity below 285 nm. This means that a secondary 
reaction takes place at protein A-excess or that protein 
A is bound to the complex at one more site on the 
Fc-surface. In this reaction tyrosine and phenylalanine 
residues are involved. 
It is certainly not possible to definitely conclude 
which component in the system the amino acids 
participating in the interaction belong to. However, 
all the four tyrosines in protein A have such a position 
on the surface that they indeed can take part in the 
reaction [ 131 and they have also been shown to be 
essential for the reaction [IO- 121. Consequently, 
the ellipticity changes seen at least partly should 
originate from them. Protein A, moreover, exhibits 
very typical CD bands ascribed to the phenylalanine 
residues [ 131. In the complexes these bands are 
largely lost and if the ellipticity is not exactly matched 
by an induced ellipticity in the Fc-fragment, also at 
least some phenylalanine residues from protein A are 
involved in the conformational change. If that is the 
case, the changes seem to be radical, as the phenyl- 
alanine residues are deeply buried, as they are not 
easily affected by neither temperature nor high salt 
concentration, as judged by CD studies [ 131. 
The results thus indicate that extensive conforma- 
tional changes take place in both the protein com- 
ponents, when protein A interacts with the Fc-part 
of IgG molecules. When protein A reacts with intact 
human IgGl, IgG2 and IgG4, the interaction is follow- 
ed by the same immunological reactions as a common 
antigen-antibody reaction both in vitro and in vivo 
[7-91. As the structure of the Fc-fragments are 
constant, the CD changes seen thus should reflect 
conformational changes similar to those taking place 
in a normal antigen-antibody reaction. In the system 
studied, phenylalanine, tyrosine and tryptophan 
residues have been shown to be involved. 
Also in studies on hapten-antibody systems, tyro- 
sine and tryptophan residues have been shown to be 
involved. Thus, e.g. Holowka et al. [22] showed by 
CD studies that three antibody populations isolated 
by isoelectric focusing bound a capsular hexasaccharide 
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in such a way, that the conformation around trypto- 
phan and tyrosine residues was changed. Litman et 
al. [23] concluded from difference spectroscopy 
studies on turtle and duck antibodies towards 
dinitrophenol groupings, that tyrosine residues were 
situated at the binding sites. The amino acid residues 
mentioned are thus parts of the IgG binding sites. If 
tyrosines also are present on the Fc-sites for protein 
A in addition to those in protein A taking part in the 
reaction cannot be concluded from the present results. 
It should, however, be mentioned in this context, that 
active and apparently monovalent fragments of 
protein A containing one tyrosine residue have been 
isolated after trypsin digestions (Hjelm, H., Sjodahl, 
J. and Sjoquist, J. (1974) personal communication). 
Further CD studies on the Fc-complex with these 
fragments or chemically modified protein A frag- 
ments hould provide better possibilities for a differen- 
tiation of the CD effects seen. 
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